UTI Inc.

UTI Inc.

179900.KQ
UTI Inc.KR flagKOSDAQ
3,910.00
KRW
-185.00
- -
76.56BMarket Cap

Total Valuation

UTI Inc. carries a market capitalization of 76.56B, placing it among publicly traded companies globally. Its enterprise value stands at 338.36B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap76.56B
Enterprise Value338.36B

Share Statistics

UTI Inc. currently has 19.58M shares outstanding.

Shares Outstanding19.58M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 14.18, and the price-to-book ratio stands at -3.59.

PE RatioN/A
PS Ratio14.18
PB Ratio-3.59
P/TBV Ratio5.68
P/FCF Ratio5.86
P/OCF Ratio-7.69

Enterprise Valuation

EV / Sales16.89
EV / EBITDAN/A
EV / EBITN/A
EV / FCF5.70

Financial Position

UTI Inc. maintains a current ratio of 0.44, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 157.00, indicating elevated leverage, while an interest coverage ratio of -5.54 demonstrates limited ability to service its debt obligations.

Current Ratio0.44
Quick Ratio0.27
Debt / Equity157.00
Debt / EBITDA-1.71
Interest Coverage-5.54

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-21.40
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)115.85
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover3.39

Taxes

Over the trailing twelve months, UTI Inc. has paid 5.75B in income taxes, reflecting an effective tax rate of 156.62.

Income Tax5.75B
Effective Tax Rate156.62

Stock Price Statistics

UTI Inc.'s stock has declined approximately -83.90947% over the past 52 weeks. The 50-day moving average sits at 15,462.20, while the 200-day moving average is 21,033.90.

Beta (5Y)N/A
52-Week Price Change-83.90947%
50-Day Moving Average15,462.20
200-Day Moving Average21,033.90
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, UTI Inc. generated 20.04B in revenue and converted that into -41.63B in net income, yielding earnings per share of -2,229.05. EBITDA reached -51.81B, while operating income came in at -51.81B.

Revenue20.04B
Gross Profit-21.27B
Operating Income-51.81B
Pretax Income-35.88B
Net Income-41.63B
EBITDA-51.81B
EBIT-51.81B
Earnings Per Share (EPS)-2,229.05

Balance Sheet

UTI Inc. holds 34.32B in cash and equivalents against 88.59B in total debt, resulting in a net debt position of 51.59B. Total book value stands at -79.08B, with working capital of -70.50B providing operational flexibility.

Cash & Cash Equivalents34.32B
Total Debt88.59B
Net Debt51.59B
Equity (Book Value)-79.08B
Book Value Per Share-4,233.92
Working Capital-70.50B

Cash Flow

UTI Inc. produced -36.96B in operating cash flow over the past twelve months. After subtracting -85.48B in capital expenditures, free cash flow totaled -122.44B - equivalent to -6,555.87 per share.

Operating Cash Flow-36.96B
Capital Expenditures-85.48B
Free Cash Flow-122.44B
FCF Per Share-6,555.87

Margins

UTI Inc. operates with a gross margin of -106.14, reflecting its pricing power and cost economics. The operating margin of -258.57 and net profit margin of -207.74 provide insight into operational efficiency.

Gross Margin-106.14
Operating Margin-258.57
Pretax Margin-179.05
Profit Margin-207.74
EBITDA Margin-258.57

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-45.23
FCF Yield17.08

Stock Splits

UTI Inc.'s most recent stock split took place on November 8, 2018 with a 1:3 split ratio.

Last Split Date11/8/2018
Split Ratio1:3

Scores

UTI Inc. posts an Altman Z-Score of -0.63, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-0.63